Cytogenetic characterization and evaluation of c-MYC gene amplification in PG100, a new Brazilian gastric cancer cell line

Brazilian Journal of Medical and Biological Research

Volumn 43, Issue 8, 2010, Pages 717-721

  Ribeiro, H F ^a   Alcantara D F A ^a   Matos, L A ^a   Sousa, J M C ^a   Leal, M F ^b   Smith, M A C ^b   Burbano, R R ^a   Bahia, M O ^a  

^a FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Carcinogenesis; Chromosomal abnormalities; Gastric cancer; Oncogenes

Indexed keywords

PROTEIN P53;

ADULT; ARTICLE; BRAZIL; CANCER CELL CULTURE; CELL ISOLATION; CHROMOSOMAL INSTABILITY; CHROMOSOME 5P; CHROMOSOME 8; CHROMOSOME DELETION; EXPERIMENTAL MODEL; GENE AMPLIFICATION; GENETIC TRAIT; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; KARYOTYPE; MALE; METAPHASE; ONCOGENE C MYC; STOMACH ADENOCARCINOMA; TRISOMY;

EID: 77957119619     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2010007500068     Document Type: Article

References (20)

1. Brenner H, Rothenbacher D, Arndt V. Epidemiology of stomach cancer. Methods Mol Biol 2009; 472: 467-477.
2. Calcagno DQ, Leal MF, Seabra AD, Khayat AS, Chen ES, Demachki S, et al. Interrelationship between chromosome 8 aneuploidy, C-MYC amplification and increased expression in individuals from northern Brazil with gastric adenocarcinoma. World J Gastroenterol 2006; 12: 6207-6211.
3. Buffart TE, Carvalho B, Mons T, Reis RM, Moutinho C, Silva P, et al. DNA copy number profiles of gastric cancer precursor lesions. BMC Genomics 2007; 8: 345.
4. Lima EM, Rissino JD, Harada ML, Assumpcao PP, Demachki S, Guimaraes AC, et al. Conventional cytogenetic characterization of a new cell line, ACP01, established from a primary human gastric tumor. Braz J Med Biol Res 2004; 37: 1831-1838.
5. Calistus Jude AL, Sasikala K, Chandrasekar TS, Ashok Kumar R, Sudha S, Vimala Devi M, et al. Cytogenetic findings in cancerous and non-cancerous lesions of the digestive system. Int J Hum Genet 2005; 5: 199-203.
6. Fernandez PC, Frank SR, Wang L, Schroeder M, Liu S, Greene J, et al. Genomic targets of the human c-Myc protein. Genes Dev 2003; 17: 1115-1129.
7. Herold S, Herkert B, Eilers M. Facilitating replication under stress: an oncogenic function of MYC? Nat Rev Cancer 2009; 9: 441-444.
8. Panani AD. Cytogenetic and molecular aspects of gastric cancer: clinical implications. Cancer Lett 2008; 266: 99-115.
9. Leal MF, Martins do Nascimento JL, da Silva CE, Vita Lamarao MF, Calcagno DQ, Khayat AS, et al. Establishment and conventional cytogenetic characterization of three gastric cancer cell lines. Cancer Genet Cytogenet 2009; 195: 85-91.
10. Rio de Janeiro Cell Bank. http://www.nce.ufrj.br/bcrj/busca1.asp?bcrj=HP005. Accessed June 7, 2010.
11. Mitelman F. ISCN: An international system for human cytogenetics nomenclature. Basel: 2005.
12. Seizinger BR, Klinger HP, Junien C, Nakamura Y, Le Beau M, Cavenee W, et al. Report of the committee on chromosome and gene loss in human neoplasia. Cytogenet Cell Genet 1991; 58: 1080-1096.
13. Ottini L, Falchetti M, Lupi R, Rizzolo P, Agnese V, Colucci G, et al. Patterns of genomic instability in gastric cancer: clinical implications and perspectives. Ann Oncol 2006; 17 (Suppl 7): vii97-102.
14. Calcagno DQ, Leal MF, Taken SS, Assumpcao PP, Demachki S, Smith MA, et al. Aneuploidy of chromosome 8 and C-MYC amplification in individuals from northern Brazil with gastric adenocarcinoma. Anticancer Res 2005; 25: 4069-4074.
15. Eilers M, Eisenman RN. Myc's broad reach. Genes Dev 2008; 22: 2755-2766.
16. Takahashi Y, Nagata T, Asai S, Shintaku K, Eguchi T, Ishii Y, et al. Detection of aberrations of 17p and p53 gene in gastrointestinal cancers by dual (two-color) fluorescence in situ hybridization and GeneChip p53 assay. Cancer Genet Cytogenet 2000; 121: 38-43.
17. Stamouli MI, Ferti AD, Panani AD, Raftakis J, Consoli C, Raptis SA, et al. Application of multiplex fluorescence in situ hybridization in the cytogenetic analysis of primary gastric carcinoma. Cancer Genet Cytogenet 2002; 135: 23-27.
18. Kaurah P, MacMillan A, Boyd N, Senz J, De Luca A, Chun N, et al. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA 2007; 297: 2360-2372.
19. Takeno SS, Leal MF, Lisboa LC, Lipay MV, Khayat AS, Assumpcao PP, et al. Genomic alterations in diffuse-type gastric cancer as shown by high-resolution comparative genomic hybridization. Cancer Genet Cytogenet 2009; 190: 1-7.
20. Kleeff J, Huang Y, Mok SC, Zimmermann A, Friess H, Buchler MW. Down-regulation of DOC-2 in colorectal cancer points to its role as a tumor suppressor in this malignancy. Dis Colon Rectum 2002; 45: 1242-1248.